'Rogue' Online Pharmacies Are Dispensing Cancer Drugs Shady sites with little oversight are selling imatinib for much less than U.S. retail price Jul 29, 2022
Therapeutic Use of Cannabis: Risks, Benefits, Legality Increased availability and use challenge clinician knowledge to keep pace Jun 29, 2022
Liquid Biopsy May Save Colon Cancer Patients From Chemo Circulating tumor DNA could determine who needs more therapy Jun 06, 2022
Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphoma Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
Chemo-ICI Combo Promising in Soft Tissue Sarcoma PFS rate of 69% at 12 weeks in liposarcoma patients with eribulin and pembrolizumab Nov 14, 2021
The Cost of Blood Platelets Is About to Surge FDA's flawed new guidance for blood transfusion safety takes effect October 1 Sep 30, 2021
Improved DFS, but No OS Boost, With Chemo in CRC With Liver Metastases Longer disease-free survival did not mean longer overall survival for these patients Sep 28, 2021
Transarterial Radioembolization Slows Progression of CRC With Liver Mets Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
Androgen-Targeting Combos Show Promise in Prostate Cancer Trials extend survival in hormone-sensitive disease Sep 21, 2021
Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
Could Docetaxel Have Role in Unfavorable-Risk Prostate Cancer? Use of chemo reduced radiation-induced cancers, and may prolong OS in low-PSA subgroup Jul 07, 2021
Tweaking Maintenance Options in Metastatic CRC Two studies move the needle, but no major breakthroughs Jun 11, 2021
Perioperative Chemo Enough in Esophageal Cancer? MAGIC/FLOT regimens yielded similar overall survival to multimodal CROSS regimen Jun 06, 2021
Adding Chemo to Standard Care No Help for Cervical Cancer Similar OS, PFS, and patterns of recurrence, with more toxicity Jun 04, 2021
PD-L1 Inhibitor Thwarts Recurrence in Early Lung Cancer Risk of death, recurrence 34% lower with atezolizumab after surgery and chemo May 19, 2021
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
What to Do With a Rare, Aggressive Bladder Cancer Case authors lament scant information on treatments or outcomes Apr 26, 2021
Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
Anti-PD-L1 Flops in Locally Advanced Head and Neck Cancer No PFS benefit from adding avelumab to chemoradiation, hazard ratio favored placebo Apr 02, 2021
HIPEC Combo Doubles PFS in Advanced Ovarian Cancer Cisplatin/paclitaxel boosts outcomes without increasing complications in registry study Mar 26, 2021
Little Benefit With Adjuvant Therapy for High-Risk Endometrial Cancer Chemo prevented relapse but did not improve survival, no benefit from radiotherapy Mar 23, 2021
Practice-Changing Trial in Second-Line Endometrial Cancer Pembrolizumab plus lenvatinib improved median OS by nearly 7 months versus chemotherapy Mar 19, 2021
New Drug OK'd for Chemo-Induced Myelosuppression in SCLC CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
Survival Boost in Bladder Cancer With Antibody-Drug Conjugate Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
Anti-CD20 Drugs Tied to Severe COVID in Cancer Patients Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
Optimizing Neoadjuvant Therapy for Breast Cancer ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
Dustin Diamond's Small Cell Lung Cancer "Saved by the Bell" actor diagnosed after exhaustive testing Feb 02, 2021
KRAS Inhibitor Continues to Impress in NSCLC Sotorasib yielded deep and durable responses in over one-third of patients Feb 01, 2021
Nab-Paclitaxel as Possible Option for Relapsed NSCLC Noninferior to docetaxel for OS, though impact on clinical practice questioned Feb 01, 2021
Should COVID-Strained Centers Hit Pause on Lung Cancer Screening? A debate on what stopping scans would do to health systems, patients Feb 01, 2021
Montana Oncologist Fired for Misdiagnosing, Overtreating Patients But some rally around him Jan 26, 2021
Preop RT Flunks Test in Borderline Pancreatic Cancer Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancer No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
